FILTER

FILTERED INTERVIEW RESULTS

Wu Yifang

CEO, FOSUN PHARMA
Fosun Pharma is a leading pharma company in China with innovative and global ambitions.

Dr. Jim Li

CEO, SUNDIA
Sundia is a CRO based in China and speaks to GBR of the evolution of the drug discovery process in China.

Dr. Xu Jia

CONSULTING LEADER, PWC CHINA HEALTHCARE AND PHARMACEUTICALS
PwC in China is benefitting from the rise of the biopharma and a flurry of IPO and acquisition activities in the pharma industry more generally.

Jay Dong

GENERAL MANAGER and GLOBAL VP, CST CHINA
CST is expanding its footprint across China where R&D and innovation spending is on the rise.

Jonathan Zhu

PARTNER PRACTICE LEADER, CHINA LIFE SCIENCE & GOVERNMENT AFFAIRS, HEIDRICK & STRUGGLES
H&S is one of the top five recruiting firms globally and is expanding its services in China’s rapidly growing life science sector.

Dr. Wu Xiaobing

COUNTRY MANAGER, PFIZER CHINA & REGIONAL PRESIDENT, PFIZER ESSENTIAL HEALTH GREATER CHINA
Pfizer speaks to GBR about its operations in China.

Ningling Wang

MANAGING PARTNER, FINNEGAN
Finnegan in Shanghai helps Chinese companies protect and enforce their IP in the US and also helps foreign clients with patent litigation in China.

Greg Scott

CEO, CHINABIO CONSULTING
ChinaBio morphed from being an angel investor in China to becoming a consultant for foreign compa-nies looking to enter the Chinese life science space.

Conrad Bucheleres, Wei Hong & Yong Zhang

AZELIS GREATER CHINA
Azelis sources an increasing array of speciality chemicals in China and distributes across the world.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

MINPER 2019 - Guía Oficial de Inversiones de Perumin

PARTNERS